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Abstract 
N-3554S, an optically active S-isomer of a-dihydrodecaprenyl phosphate, reduced the tumorigenicity of cultured B16-F10 mouse 
melanoma cells probably by affecting protein N-glycosylation. Accordingly, membrane glycoprotein samples were prepared from the 
melanoma cells cultured with or without N-3554S, and amounts and structures of N-linked sugar chains were determined. Analyses of the 
N-linked oligosaccharides released by hydrazinolysis from these samples and reduced with NaB3H4 revealed that the N-3554S-treated 
cells contain 1.5-1.8 times as nmch oligosaccharides as the control cells, and the relative amounts of high-mannose-type and bi-, tri- and 
tetra-antennary complex-type sugar chains are almost the same between two samples. Western blot analysis, however, showed that 
binding of L-PHA, which bind,,; to oligosaccharides with the GlcNAc/31 ~ 6(GIcNAc/3 1 ~ 2)Man structure, is significantly reduced in 
90 K, 96 K, 140 K, 155 K and 180 K glycoproteins in N-3554S-treated cells. Immunoblot analysis howed that the 140 K glycoprotein 
could be a fibronectin receptor. It was also shown that N-3554S treatment enhances the adhesiveness of the cells to fibronectin. These 
results indicate that N-3554S affects N-glycosylation of membrane glycoproteins and alters the cell surface properties of B 16-F10 cells. 
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1. Introduction 
N-Linked sugar chains of cell surface glycoproteins i
known to play important roles in tumor metastasis [1,2] 
and in interactions between host immunocytes and tumor 
cells [3,4]. Several studies have revealed that alterations of 
the N-linked sugar chains of tumor cell surface glyco- 
proteins are associated with the malignant phenotypes 
[5-10]. 
A precursor of N-linked sugar chains, G lc3 .Man 9- 
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GlcNAc2, is formed on dolichyl pyrophosphate via lipid 
intermediate pathway [l 1]. a-Dihydrodecaprenyl phos- 
phate containing 8 trans internal isoprene residues has 
been shown to function as a mannose carder like dolichyl 
phosphate in the lipid intermediate pathway, and stimulate 
protein N-glycosylation i cultured hepatoma cells [12,13]. 
It was also shown that a-dihydrodecaprenyl phosphate 
inhibits growth and pulmonary metastasis of B l6-F10 
mouse melanoma in syngeneic mice [14]. 
a-Dihydrodecaprenyl phosphate has an asymmetric cen- 
ter at the carbon-3, and, therefore, consists of two optically 
active isomers, S- and R-forms. Since natural dolichyl 
phosphate has an S-configuration at the C-3 position [15], 
we chemically synthesized (S)-a-dihydrodecaprenyl phos- 
phate (N-3554S) and examined effects of N-3554S on 
tumorigenicity and protein N-glycosylation in cultured 
Bl6-F10 cells. In addition, effect of the compound on 
adhesiveness of the cells to fibronectin was also examined, 
because altered N-glycosylation of a fibronectin receptor- 
like glycoprotein was detected. 
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2. Materials and methods 
2.1. Chemicals 
Con A-Sepharose and DSA-Sepharose were purchased 
from Pharmacia Fine Chemical (Tokyo) and Wako Pure 
Chemical  (Tokyo),  respectively. NaBaH4 (600 
mCi/mmol)  was purchased from New England Nuclear 
(Boston, MA), and Arthrobactor ureafaciens ialidase was 
obtained from Nacarai Tesque (Kyoto). Diplococcal /3- 
galactosidase and diplococcal /3-N-acetylhexosaminidase, 
and jack bean /3-galactosidase were purchased from 
Boehringer Mannheim-Yamanouchi (Tokyo) and Seika- 
gaku (Tokyo), respectively. Jack bean /3-N-acetylhexosa- 
minidase and a-mannosidase, and Aspergillus saitoi a- 
mannosidase I were purified by the methods described 
previously [16,17]. Peroxidase-conjugated Con A and L- 
PHA were purchased from EY Laboratories (San Mateo, 
CA). Rabbit anti-human fibronectin receptor (as/3! inte- 
grin) antiserum and peroxidase-conjugated mouse anti-rab- 
bit IgG were the products of Chemicon International 
(Temecula, CA) and Rockland (Gilbertsville, PA), respec- 
tively. Bovine plasma fibronectin was purchased from 
Nitta Gelatin (Osaka). Trypsin (1:250) was the product of 
Difco Laboratories (Detroit, MI). 
2.2. Synthesis ofN-3554S 
N-3554S was prepared by chemical modification of 
solanesol. In brief, all-E decaprenol which was prepared 
from solanesyl acetone [12] was subjected to enantioselec- 
tive hydrogenation using Ru-(OCOCHa)[(R)-BINAP] as a 
catalyst [18-20] to give (S)-a-dihydrodecaprenol, and the 
latter compound was phosphorylated using phosphorus 
oxychloride. The [a]~ 5 value and the optical purity of 
N-3554S thus obtained were -1 .61 ° and 96.6% e.e., 
respectively. 
2.3. Treatment of B16-FlO cell with N-3554S 
B16-F10 cells were maintained in RPMI 1640 medium 
containing 10% fetal bovine serum and antibiotics as 
previously described [14]. The cells (2.5 X 105) suspended 
in l0 ml of the medium were seeded on to a plastic dish 
(Falcon No. 3003). At day l after seeding, N-3554S 
dissolved in 50/xl  of dimethyl sulfoxide was added to the 
dish to make a final concentration of l0 /zg/ml.  The 
vehicle alone was added to the control dish. Cells were 
cultured for 3 more days. 
2.4. Preparation of glycoprotein samples 
After B16-F10 cells were treated with N-3554S, cells 
were washed with PBS twice, and harvested by a rubber 
policeman. The cells pelleted by centrifugation at 1000 
rpm for 5 min were suspended in 10 volumes of ice-cold 1 
mM NaHCO3-0.5 mM CaCI 2 (pH 7.5) and stood on ice 
for 30 min. Swollen cells were homogenized using a 
glass-Teflon homogenizer, and homogenates were cen- 
trifuged at 12 000 × g for 30 min. The pellets were defat- 
ted with acetone and chloroform-methanol mixtures (2:1 
and 1:2, v /v )  to prepare membrane glycoprotein samples 
[5]. 
2.5. Liberation of N-linked sugar cha&s from glycoprotein 
samples 
The samples, dried thoroughly in vacuo over P205, 
were subjected to hydrazinolysis to release N-linked oligo- 
saccharides. After N-acetylation, a liberated oligosaccha- 
ride mixture was reduced with NaB3H4 to obtain tritium- 
labeled oligosaccharides for structural analysis [21]. 
2.6. Structural analysis of oligosaccharides 
Essentially, the oligosaccharide structures were deter- 
mined by sequential exoglycosidase digestion. Fractiona- 
tion of radioactive oligosaccharides by high-voltage paper 
electrophoresis and Bio-Gel P-4 chromatography were per- 
formed as described previously [22]. Lectin column chro- 
matography using columns containing Con A-Sepharose 
and DSA-Sepharose was performed as described previ- 
ously [23,24]. Oligosaccharides (1-100 X 10 3 cpm)were 
digested with exoglycosidases under the previously de- 
scribed conditions [25]. 
2.7. Standard oligosaccharides 
The origins of the following oligosaccharides were as 
fo l lows:  Ga l f l l  -~ 4GlcNAcf l l  ~ 6 (Ga l f l l  -~ 
4GlcNAc/31 -~ 2)Man c~ 1 ~ 6[Gal/31 -~ 4Glc NAc/31 -~ 
4(Gal/3 1 -~ 4GlcNAc/31 -~ 2)Man ce 1 -~ 3]Man/31 --* 4 
G lcNAc/a l  ~ 4 (Fucc~l ~ 6)GlcNACoT (Gal 4 
GlcNAc 4 • Man a • GlcNAc • Fuc • GlcNACoT), Gal/31 
4GlcNAc/31 ~ 2Man a I ~ 6[Gal/31 ~ 4GlcNAc/31 -~ 
4(Gal/31 -~ 4GlcNAc/31 ~ 2)Mana l  --* 3]Man/al 
4GlcNAc/31 -~ 4(Fuc c~ 1 -~ 6)GlcNACoT (2,4-branched 
Gal a • GlcNAc 3 • Man a • GlcNAc • Fuc • GlcNACoT), and 
Gal/31 -~ 4GlcNAc/31 -~ 6(Gal/31 ~ 4GlcNAc/3 1 
2)Man c~ 1 -~ 6(Gal/31 -~ 4GIcNAc/31 -~ 2Man t~ 1 -~ 
3)Man/3 1 -~ 4GlcNAc/3 1 ~ 4(Fuc ce 1 -~ 6)GIcNACoT 
(2,6-branched Gal a • GlcNAc 3 • Man a • GlcNAc • Fuc • 
GlcNACoT), were obtained from human blood coagulation 
factor VIII [25]. Neu5Ac a 2 ~ 6Gal/31 ~ 4GlcNAc/31 
-~ 2Man a 1 ~ 6(Neu5Ac a 2 ~ 6Gal/31 ~ 4GlcNAc/3 1 
2Mana l  -~ 3)Man/31 ~ 4GlcNAc/31 -0 4GlcNACoT 
(Neu5Ac 2 • Gal 2 • GlcNAc 2 .Man 3 • GlcNAc • GlcNACoT), 
and Neu5Ac a 2 ~ 6Gal/31 ~ 4GlcNAc/31 -~ 2Man cr 1 
6 or 3(Gal/31 ~ 4GlcNAc/31 ~ 2Man a 1 -~ 3 or 6) 
Man/31 -~ 4GlcNAc/31 ~ 4GlcNACoT (Neu5Ac • Gal 2 • 
GlcNAc 2 • Man a • GlcNAc • GlcNAcov), were prepared 
from human transferrin [26] by hydrazinolysis, and its 
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desialylated oligosaccharide (Gal 2 • GlcNAc 2 • Man 3 • 
GlcNAc-  GlcNAcoT), was prepared by digestion with A. 
ureafaciens sialidase. Gal fl 1 ~ 4GIcNAc/31 ~ 2Man cr 1 
6(Gal/3 1 ~ 4GIcNAc/31 --* 2Man a 1 ~ 3)Man/3 1 --* 
4GlcNAc/31 ---, 4(Fuc c~ 1 --, 6)GIcNAcoT (Gal 2 "GlcNAc 2 
• Man 3 • GIcNAc • Fuc.  GIcNACoT), was prepared from 
human platelet hrombospondin [27]. Man a 1 ~ 6(Man c~ 1 
--, 3)Man/31 ~ 4GlcNAc/31 ~ 4GlcNACoT (Man 3 • 
GlcNAc • GlcNAcoT),  and Mante l  -~ 6(Mante l  
3)Man/31 --, 4GlcNAc/31 --* 4(Fuc a 1 ---, 6)GlcNACoT 
(Man 3 • GlcNAc • Fuc • GlcNACoT), were obtained from 
Gal 2 • GlcNAc 2 • Man 3 • GIcNAc • GIcNACoT and Gal 2 - 
GlcNAc 2 .Man 3 • GlcNAc • Fuc • GIcNACoT, respectively, 
by digestion with diplococcal /3-galactosidase followed by 
dip lococcal  /3-N-acetylhexosaminidase. Man/3 1 
4GlcNAc/31 ~ 4GlcNACoT (Man.  GlcNAc.  GIcNAcoT), 
and Man/31 ---, 4GlcNAc/31 ~ 4(Fuc c~l ~ 6)GlcNAcoT 
(Man.  G lcNAc-Fuc  • GIcNACoT), were prepared from 
Man 3 • GlcNAc • GlcNAcoT, and Man 3 • GlcNAc • Fuc • 
GlcNACoT, respectively, by digestion with jack bean a- 
mannosidase. Man a 1 -~ 6(Man cr 1 ~ 3)Man c~ 1 
6(Mante l  --, 3)Man/31 ~ 4GlcNAc/31 ~ 4GlcNACoT 
(Man 5 • GlcNAc.  GlcNAcoT), was obtained from bovine 
pancreatic ribonuclease B [28]. 
the fibronectin-coated well and allowed to attach for 2 h at 
37°C in a humidified atmosphere of a i r /CO 2 (19:1)• In 
these conditions, essentially all of the cells were attached 
to the fibronectin substrate. At the end of the attachment 
period, the medium was removed by aspiration and 1 ml of 
100 ng /ml  trypsin in PBS was added to the well. The 
wells were incubated in the presence of trypsin at 37°C for 
various periods and the number of detached cells in each 
well was counted using a hemocytometer. Differences in 
cell numbers were analyzed with Student's t-test. 
2• 10. Assay of tumorigenicity of cells 
BI6 -F I0  cells treated with N-3554S for 3 days and the 
control cells were harvested and suspended in a serum-free 
RPMI 1640 medium as described above• Viable cells (10 4) 
were subcutaneously inoculated into the right flank of 
male 6-week-old C57BL/6  mice (Shizuoka Agricultural 
Association for Laboratory Animals, Shizuoka). After in- 
oculation, the occurrence of visible tumors was examined, 
and the sizes (means of the longest and the shortest 
diameters) of the tumors formed were measured. Differ- 
ences in the tumor sizes were analyzed using Mann-Whit- 
ney U-test. 
2•8• SDS-PAGE and Western blotting 
Membrane glycoprotein samples were solubilized in the 
sample buffer solution for e]lectrophoresis a described by 
Laemmli [29]. SDS-PAGE followed by lectin blot analysis 
was performed by the method described previously [30], 
except hat PVDF filters (Ilmnobilon-P; Mill ipore Corpora- 
tion, Bedford, MA) instead of nitrocellulose filters were 
used for protein transfer. Immune blot analysis was also 
performed by incubating a blotted filter with rabbit anti- 
fibronectin receptor antiserum followed by further incuba- 
tion with peroxidase-conjugated mouse anti-rabbit IgG. 
Protein-bound peroxidase was detected using POD Im- 
munostain Set (Wako Pure Chemical). 
3. Resul ts  
3.1• Effect ofN-3554S on tumorigenicity of B16-FIO cell 
The effect of N-3554S on the tumorigenicity of B 16-F10 
cells was examined• As shown in Fig. 1, the control cells 
subcutaneously inoculated to mice began to form tumors at 
day 15 after inoculation• When the cells were treated with 
10 /xg/ml  N-3554S prior to inoculation, tumor formation 
was delayed and detected as late as at day 21. The 
frequency of tumor formation in mice at day 28 was 70% 
and 40% in the control and the N-3554S-treated cells, 
2•9• Adhesion assay of cells 
A 24-well plastic plate (Falcon No. 3047) was coated 
with fibronectin (10 /xg/m]l PBS) and blocked with 1% 
heat-denaturated bovine serum albumin• The plate was 
then thoroughly rinsed with PBS. 
B16-F10 cells treated with N-3554S for 3 days and the 
control cells were detached from the dish by the treatment 
with 0.05% trypsin/0.02% EDTA at 37°C for 2 min and 
suspended in RPMI 1640 medium containing 10% fetal 
bovine serum• After the numbers of cells excluding trypan 
blue were counted in a hemocytometer, the cells were 
centrifuged and resuspended in serum-free RPMI 1640 
medium containing 10 /xg/ml  N-3554S (N-3554S-treated 
cells or the vehicle alone (control cells)• Viable cells 
(3 × 105) in 1 ml of the serum-free medium were added to 
80 
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Fig. l. Effect of N-3554S on tumorigenicity of B16-F10 cells. Control 
(O) and N-3554S-treated (O) cells were subcutaneously inoculated into 
each 10 mice and the tumor formation was examined as described in 
Section 2. 
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Table 1 
Effect of N-3554S on N-glycosylation of membrane glycoproteins from 
B16-F10 mouse melanoma cells 
Experiment no. [3H]Oligosaccharides (10 -4 )< cpm/mg dry weight) 
Control (a) N-3554S-treated (b) Ratio (b)/(a) 
1 9.34 14.32 1.53 
2 6.62 11.75 1.77 
Membrane glycoprotein samples were prepared from the control and 
N-3554S-treated B16-F10 cells. Tritium-labeled oligosaccharides were 
obtained by hydrazinolysis followed by reduction with NaB3H4. 
respectively. Furthermore, the mean tumor size in the 
N-3554S-treated cells (3.6 + 1.5 cm) was significantly 
smaller (P  < 0.05) than that in the control cells (8.1 + 2.2 
cm) at day 28. Essentially the same result was obtained in 
another experiment. A similar but less effect was obtained 
from the cells treated with 1 /zg/ml N-3554S (the fre- 
quency of tumor formation was 44% and the mean tumor 
size was 5.9 + 2.6 cm at day 28) as compared with that 
from the cells treated with 10 /zg/ml N-3554S. When the 
cells pretreated with 10 /~g/ml N-3554S and the control 
cells were suspended in the standard growth medium 
without the drug and cultured for 4 days, no difference in 
the proliferation rate was detected during the culturing 
period. 
These results suggest hat N-3554S reduces the tumori- 
genicity probably by affecting N-glycosylation i the cells. 
Therefore, amounts and structures of the N-linked sugar 
chains from the N-3554S-treated and control cells were 
examined and compared. 
3.2. Liberation and separation of oligosaccharides 
The N-linked sugar chains of the membrane glyco- 
protein samples prepared from N-3554S-treated and con- 
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Fig. 2. Paper electrophoresis of oligosaccharides released from membrane 
glycoprotein samples of the control (a) and N-3554S-treated cells (b). 
Arrows at the top of the figure indicate the positions to which authentic 
oligosaccharides migrated: (1), lactitol; (II), Neu5Ac.Gal2.GlcNAc 2. 
Man 3 . GlcNAc • GlcNACoT; (III), Neu5Ac 2 • Gal 2 • GlcNAc 2 • Man 3 - 
GIcNAc. GlcNAco- r. 
trol cells were quantitatively iberated as oligosaccharides 
by hydrazinolysis and then reduced with NaB3H4 . From 
the treated samples, about 1.5 and 1.8 times as much 
radioactive oligosaccharides a  the control samples were 
obtained in two separate xperiments (Table 1). In the 
experimental conditions used, N-3554S caused no signifi- 
cant effect on the growth rate of the cells nor on the 
protein content of the membrane glycoprotein samples 
prepared from the cells. Accordingly, the result indicates 
that N-3554S increases the number of N-linked sugar 
chains in membrane glycoproteins. 
The radioactive oligosaccharides from both samples 
were subjected to paper electrophoresis, and separated into 
neutral (N) and acidic (A) fractions as shown in Fig. 2. 
Though the electrophoretic patterns are somewhat different 
between the control and the N-3554S-treated samples, the 
0 
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Fig. 3. Sequential exoglycosidase digestion of Con A fractions. The 
fraction and its digestion products were analyzed by Bio-Gel P-4 column 
chromatography: (A) fraction Con A+; (B) oligosaccharides indicated by 
a horizontal bar in panel A digested with a mixture of diplococcal 
fl-galactosidase and diplococcal fl-N-acetylhexosaminidase; (C) fraction 
Con A++; (D) oligosaccharides in panel C digested with A. saitoi 
c~-mannosidase I; (E) oligosaccharide in panel D digested with jack bean 
ce-mannosidase; (F) fraction Con A- ;  (G) oligosaccharides in panel F 
digested with a mixture of jack bean fl-galactosidase and jack bean 
fl-N-acetylhexosaminidase. The arrowheads at the top of the figure 
indicate elution positions of glucose oligomers used as internal standards, 
and the numbers indicate glucose units. Bold arrows indicate the elution 
positions of authentic oligosaccharides: (I) Mans.GlcNAc. GlcNAcor; 
(II) Gal 2 • GlcNAc 2 • Man 3 • GlcNAc - Fuc • GIcNAcoT; (III) Gal 2 • 
GlcNAc 2" Man 3" GlcNAc • GIcNACoT; (IV) Man. GlcNAc • GIcNAcoT. 
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percent molar ratios of the fractions N and A calculated 
from their radioactivities were 30% and 70% for both 
samples. When the fraction A from both samples were 
digested with A. ureafaciens ialidase, all of the acidic 
oligosaccharides were converted to neutral ones (AN) (data 
not shown), indicating that 1:he acidic oligosaccharides are 
all sialyl derivatives. 
Oligosaccharides in the fi'actions N and AN from each 
sample were combined and subjected to Con A-Sepharose 
column chromatography. The pass-through fraction (Con 
A-),  the bound fraction eluted with 5 mM c~-methyl 
glucoside (Con A ÷) and the bound fraction eluted with 
100 mM a-methyl mannoside (Con A ÷+) were obtained. 
According to the binding specificity of the lectin [23,31,32], 
biantennary sugar chains are recovered in the weakly 
bound fraction (Con A+), high-mannose and hybrid-type 
sugar chains recovered in the strongly bound fraction (Con 
A+÷), and highly branched complex-type sugar chains 
recovered in the pass-through fraction (Con A-). The 
radioactivities recovered in the fractions Con A-, Con A ÷ 
and Con A ÷+ were 56.8%, 12.6% and 30.6% for N- 
3554S-treated sample, and 57.6%, 11.5% and 30.9% for 
the control sample, respectively. These data suggest hat 
there are no significant differences in the carbohydrate 
structures between oligosaccharides from two samples. 
Since detailed structures of N-linked sugar chains of B 16 
melanoma cell membrane glycoproteins had been exten- 
sively studied [33,34], the structures of the oligosaccha- 
rides in each Con A fraction were simply analyzed by 
sequential exoglycosidase digestion and by Bio-Gel P-4 
column chromatography. 
3.3. Exoglycosidase digestion of oligosaccharides in con 
A-fractions 
Oligosaccharides in the fraction Con A ÷ from N- 
3554S-treated sample were eluted from a Bio-Gel P-4 
column as two peaks with the same elution positions as 
Table 2 
Proposed structures of  the neutral znd desialylated N-l inked sugar chains in the control and N-3554S-treated B 16-F10 cells 
Fractions Structures ' Molar ratio (%) 
Control Treated 
ConA + + 
ConA + 
ConA 
f Mano~ 1,,~ 6 
(Man°t1->2)°-4 '~Man(xl ,I,3 
Man~ 1 ~ 6 
Manet 1 j 3 
Gal~l -->4G IcNAc ~1 -->2Mantel ,~, 6 
Ga191~4G IcNAc 91 ..-~2Manal f 3 
Man91-->4R 
Man~ 1 -->4R 
Ga191 ---,4GIcNAc ~1 --->2ManoO ~ .... 
Gall] 1--',.4GIcNAc 91,,,l~, ~)  Man91--.>4R 
- -  '+Manc~l j o~o/  
Gall31 -~4GIcNAc 91 f 2 
Gal~ 1 ->4GIcNAc I~1 ,~ 6 
Mano:l ,~ 
GalI31._>4GIcNAc 91J 2 6 !^3! Man~l-->4R 
Gal9 I._>4GIcNAc 131 ._>2 ManoO f ~t~) 
I GalJ~l --,,.4GIcNAc ~.1 ~ 6 
+(Ga191 --> J Ga191-->4GleNAc 131 f 2 Man~l ,~ 
4GIcNAc~il) / Ga191->4GIcNAc91,''~4 Man(x1 f 3(6)6(3)Man91->4R 
~. Gat91-->4GIcNAc 91 f 2 
30.9 30.6 
11.5 12.6 
18.9 19.8 
4.4 2.3 
24.1 25.8 
Not detern~ned 10.2 8.9 
R = GIcNAc fl 1 -~ 4( + Fuc a 1 ~ 6)GlcNAc OT o 
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authentic biantennary sugar chains (Fig. 3A). When oligo- 
saccharides in Fig. 3A were digested with a mixture of 
diplococcal /3-galactosidase and diplococcal /3-N- 
acetylhexosaminidase, two radioactive peaks with the elu- 
tion positions of trimannosyl cores, Man 3 • GlcNAc • Fuc • 
GlcNAcor and Man 3 • GIcNAc • GlcNACoT, were pro- 
duced (Fig. 3B). Oligosaccharides in the fraction Con A +÷ 
from N-3554S-treated sample were eluted as multiple peaks 
with more than 8 glucose units from a Bio-Gel P-4 column 
(Fig. 3C). When the peaks in Fig. 3C were digested with 
A. saitoi a-mannosidase I, a single radioactive oligo- 
saccharide was eluted at the same position as Man 5 • 
GlcNAc • GlcNACoT (Fig. 3D). After digestion of the peak 
in Fig. 3D with jack bean a-mannosidase, four mannose 
residues were released, and the radioactive product was 
eluted at the same position as Man. GlcNAc- GlcNAcor 
(Fig. 3E). Oligosaccharides in the fraction Con A from 
N-3554S-treated sample were eluted at the same positions 
as authentic tri- and tetra-antennary sugar chains from a 
Bio-Gel P-4 column (Fig. 3F). When the peaks in Fig. 3F 
were digested with a mixture of jack bean /3-galactosidase 
and jack bean /3-N-acetylhexosaminidase, two radioactive 
peaks with the same elution positions as trimannosyl cores, 
Man 3 • GlcNAc • Fuc • GlcNAcov and Man 3 • GlcNAc • 
GlcNACoT, were produced (Fig. 3G). The results of oligo- 
saccharides in the Con A fractions from control sample 
were identical to those from N-3554S-treated sample (data 
not shown). Based on the data of sequential exoglycosi- 
dase digestion as described earlier and the binding speci- 
ficity of Con A-Sepharose column, it is suggested that the 
Con A ÷, Con A ++ and Con A-  fractions from two 
samples contain bi-antennary complex-type, high-man- 
nose-type, and tri- and tetra-antennary complex-type sugar 
chains, respectively. In order to examine whether or not 
the difference in the antennary structure is included be- 
tween the oligosaccharides in the fraction Con A-  from 
two samples, the oligosaccharides in the fraction were 
subjected to DSA-Sepharose column chromatography, be- 
cause 2,4-branched tri-antennary sugar chains are recov- 
ered in the retarded fraction (DSA0 and 2,6-branched tri- 
and tetra-antennary sugar chains recovered in the bound 
fraction (DSA ÷) [24]. Similar binding patterns were ob- 
tained for both samples in the column chromatography 
(data not shown). Proposed structures of the major oligo- 
saccharides from two samples, based on the analyses de- 
scribed above, are shown in Table 2. 
3.4. Western blot analysis 
In order to examine whether N-3554S treatment of 
B16-FI0 cells induces changes in lectin binding to mem- 
brane glycoproteins, Western blot analysis was performed 
using peroxidase-conjugated Con A and L-PHA. The 
membrane glycoprotein samples prepared from B16-F10 
cells cultured in the presence or absence of N-3554S were 
subjected to SDS-PAGE, and proteins were transferred to 
PVDF filters. As shown in Fig. 4, no significant differ- 
ences were detected with CBB staining between two sam- 
ples (lanes A and B, respectively). Con A binding was also 
almost he same between two samples (Fig. 4, lanes C and 
A B C 
21 2 K - 
1 70K - 
116K-  
76K -- 
212K- -  
170K --  
116K- -  
76K- -  
D E F G H 
.,el 
41  
53K- -  53K- -  
Fig. 4. Western blot analysis of membrane glycoproteins. The glycoprotein samples prepared from control (A, C, E and G) and N-3554S-treated (B, D, F 
and H) cells were subjected to SDS-PAGE and then Western blot analysis. Amounts of samples applied to each lane were 25/xg (A and B), 30/zg (C and 
D) or 50 /xg (E-H). Blotted filters were stained with CBB (A and B), or incubated either with Con A (C and D), L-PHA (E and F) or rabbit anti-human 
fibronectin receptor antiserum (G and H) followed by visualization as described in Section 2. 
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Fig. 5. Effect of N-3554S on the adhesiveness of B16-F10 cells to 
fibronectin. Control (O) and N-3554S-treated (O)cells were attached to
fibronectin substrate for 2 h, and the rate of cell detachment by a trypsin 
treatment was measured asdescribed inSection 2. Each point shows the 
mean+ S.E.M. of triplicate determinations, t: P < 0.05, compared with 
the control. :~: P < 0.01, compared with the control. 
D), except that increased binding of the lectin to 116 K 
and 180 K glycoproteins was observed in N-3554S-treated 
sample. When the filter was; incubated with L-PHA which 
binds to complex-type sugar chains with the GlcNAc/31 
6(GlcNAc/31 ~ 2)Man-branched structure [35] (Fig. 4, 
lanes E and F), the increased binding of the lectin was 
detected in glycoproteins with molecular weights of 100 
K-130 K and the decreased binding of the lectin was also 
detected in 90 K, 96 K, 140 K, 160 K and 180 K 
glycoproteins (indicated by arrowheads in lane F) of the 
N-3554S-treated samples. These changes by N-3554S 
treatment of the cells were consistently observed in several 
experiments using three separate batches of control and the 
treated samples. 
Since altered glycosylation of fibronectin receptor 
(as/31 integrin) affects the function of the protein [36-38], 
whether or not a 140 K glycoprotein with reduced L- 
PHA-binding in N-3554S-treated cells is a fibronectin 
receptor was investigated. Incubation of the filter with 
rabbit anti-human fibronecfin receptor antiserum, which 
binds to a fibronectin receptor not only from human but 
also from mouse, showed that the protein band with an 
apparent molecular weight of 140 K is detected in both 
samples with almost similar amounts (indicated by an 
arrow in Fig. 4, lane H). The result indicates that a 140 K 
glycoprotein can be a fibronectin receptor. Since the elec- 
trophoretic mobility of the,, bands reactive to the anti- 
fibronectin receptor antibody was exactly the same be- 
tween the two samples, it was also suggested that the 
fibronectin receptor in both samples contains a similar 
number of sugar chains. 
3.5. Adhes iveness  o f  B16-F lO  cell  to f ibronect in  
Since the altered glycosylation of a fibronectin 
receptor-like glycoprotein was detected in N-3554S-treated 
cells, effect of the compound on the adhesiveness of the 
cells to fibronectin was examined. The N-3554S-treated 
and the control cells were allowed to attach to a fi- 
bronectin substrate for 2 h, and the percentages of cells 
released by a mild trypsin treatment was determined. As 
shown in Fig. 5, N-3554S-treated cells were detached from 
the fibronectin substrate more slowly than the control cells, 
indicating that the drug enhances the adhesiveness of the 
cells to fibronectin possibly via altered glycosylation of a 
fibronectin receptor. 
4. Discussion 
a-Dihydrodecaprenyl phosphate has been shown to in- 
hibit the growth and pulmonary metastasis of B16-F10 
melanoma in syngeneic mice [14]. In the present study we 
found that N-3554S, an S-isomer of a-dihydrodecaprenyl 
phosphate, reduces tumorigenicity of the cultured B 16-F10 
cells. Since a-dihydrodecaprenyl phosphate affects protein 
N-glycosylation [ 12,13], it was anticipated that the altered 
glycosylation of cell surface glycoproteins i responsible 
for the reduced tumorigenicity of the N-3554S-treated 
cells. 
Reduction of the oligosaccharides released by hydrazi- 
nolysis from membrane glycoprotein samples with NaB3H4 
revealed that the radioactivities incorporated into the oligo- 
saccharides are 1.5-1.8 times higher in the N-3554S-treated 
cells than the control cells. The result indicates that the 
number of N-linked sugar chains associated with mem- 
brane glycoproteins i  increased in the treated cells. This is 
in good agreement with the previous data showing that 
a-dihydrodecaprenyl phosphate increased the incorpora- 
tion of [~4C]glucosamine into N-linked sugar chains of 
glycoproteins by about 80% in cultured hepatoma cells 
[12]. 
Structural analyses of the N-linked sugar chains frac- 
tionated by Con A-Sepharose column chromatography re- 
vealed that membrane glycoprotein samples prepared from 
the N-3554S-treated and control cells contain high-man- 
nose-type and bi-, tri- and tetra-antennary complex-type 
sugar chains with almost similar relative amounts. In 
Western blot analysis, however, it was shown that L-PHA 
binding to individual glycoproteins i significantly altered 
in the N-3554S-treated cells. The increased binding of the 
lectin to glycoproteins with molecular weights of 100 
K-130 K and the decreased binding of the lectin to 90 K, 
96 K, 140 K, 160 K and 180 K glycoproteins were 
simultaneously observed. Since the absolute amounts of 
the L-PHA-reactive 2,6-branched tri- and tetra-antennary 
complex-type sugar chains must be increased in the mem- 
brane glycoprotein sample prepared from the N-3554S- 
treated cells, this overall increase may be attributed to the 
augmented expression of the branched sugar chains in a 
limited number of glycoproteins including those with 
molecular weights of 100 K-130 K. In conjunction with 
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the decreased binding of L-PHA to several glycoproteins 
mentioned above, the results suggest hat processing of 
N-linked sugar chains in individual glycoproteins is differ- 
ently regulated by N-3554S. The mechanism of the differ- 
ent regulation remains to be elucidated. However, it seems 
possible that, in glycoproteins undergoing rapid turnover, 
increased N-glycosylation might reduce the accessibility of 
acceptor  o l igosacchar ides to N-acety lg luco-  
saminyltransferase V, which forms the L-PHA reactive 
2,6-branched complex-type sugar chains. Rosenwald et al. 
have shown that branching of N-linked sugar chains of 
glycoproteins can be regulated by factors that affect the 
earliest reactions in oligosaccharide-lipid b osynthesis [39]. 
Immunoblot analysis with an anti-fibronectin receptor 
antibody revealed that the 140 K glycoprotein detected in 
both samples could be a fibronectin receptor. Since the 
altered glycosylation of fibronectin receptor produced by 
mouse 3T3 cells, which was treated with the processing 
inhibitor of N-linked sugar chains, reduced attachment of
the cells to fibronectin [36], altered glycosylation of the 
140 K glycoprotein obtained from the N-3554S-treated 
B16-F10 cells may alter the function of this molecule. 
Adhesion assay revealed that N-3554S enhances the adhe- 
siveness of the cells to a fibronectin substrate possibly by 
the increased affinity of the receptor to the substrate. In 
accordance with this, Olden indicates that the transforma- 
tion-associated changes in glycosylation of fibronectin re- 
ceptor could result in the decreased binding of cells to 
fibronectin [37]. 
Since high-mannose-type sugar chains are recognized 
by natural killer cells [3,4,40] and by macrophages [41], it 
seems possible that N-3554S may induce B16-F10 cells 
more susceptible to the host immune system via increasing 
high-mannose-type sugar chains on the cell surface, thereby 
reducing tumorigenicity of the cells. 
In conclusion, the present study shows that N-3554S 
affects the N-glycosylation of cellular glycoproteins and 
subsequently alters the cell surface properties of the malig- 
nant B16-F10 cells. 
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